393 related articles for article (PubMed ID: 33713286)
1. Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study.
Pastori D; Sciacqua A; Marcucci R; Del Ben M; Baratta F; Violi F; Pignatelli P;
Intern Emerg Med; 2021 Nov; 16(8):2063-2068. PubMed ID: 33713286
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and Impact of Nonalcoholic Fatty Liver Disease in Atrial Fibrillation.
Pastori D; Sciacqua A; Marcucci R; Farcomeni A; Perticone F; Del Ben M; Angelico F; Baratta F; Pignatelli P; Violi F;
Mayo Clin Proc; 2020 Mar; 95(3):513-520. PubMed ID: 31753536
[TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic Fatty Liver Disease and Fibrosis Associated With Increased Risk of Cardiovascular Events in a Prospective Study.
Baratta F; Pastori D; Angelico F; Balla A; Paganini AM; Cocomello N; Ferro D; Violi F; Sanyal AJ; Del Ben M
Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2324-2331.e4. PubMed ID: 31887443
[TBL] [Abstract][Full Text] [Related]
4. Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors.
Pastori D; Pignatelli P; Angelico F; Farcomeni A; Del Ben M; Vicario T; Bucci T; Raparelli V; Cangemi R; Tanzilli G; Lip GYH; Violi F
Chest; 2015 Jun; 147(6):1644-1650. PubMed ID: 25429521
[TBL] [Abstract][Full Text] [Related]
5. Temporal trends of time in therapeutic range and incidence of cardiovascular events in patients with non-valvular atrial fibrillation.
Pastori D; Farcomeni A; Saliola M; Del Sole F; Pignatelli P; Violi F; Lip GYH;
Eur J Intern Med; 2018 Aug; 54():34-39. PubMed ID: 29655807
[TBL] [Abstract][Full Text] [Related]
6. Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events: The ABC (Atrial fibrillation Better Care) Pathway in the ATHERO-AF Study Cohort.
Pastori D; Pignatelli P; Menichelli D; Violi F; Lip GYH
Mayo Clin Proc; 2019 Jul; 94(7):1261-1267. PubMed ID: 30551910
[TBL] [Abstract][Full Text] [Related]
7. Association of Cardiovascular Risk Factors and Metabolic Syndrome with non-alcoholic and alcoholic fatty liver disease: a retrospective analysis.
Han AL
BMC Endocr Disord; 2021 May; 21(1):91. PubMed ID: 33933056
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal.
Pardhe BD; Shakya S; Bhetwal A; Mathias J; Khanal PR; Pandit R; Shakya J; Joshi HO; Marahatta SB
BMC Gastroenterol; 2018 Jul; 18(1):109. PubMed ID: 29980170
[TBL] [Abstract][Full Text] [Related]
9. Family History of Atrial Fibrillation and Risk of Cardiovascular Events: A Multicenter Prospective Cohort Study.
Pastori D; Menichelli D; Lip GYH; Sciacqua A; Violi F; Pignatelli P;
Circ Arrhythm Electrophysiol; 2020 Sep; 13(9):e008477. PubMed ID: 32718257
[TBL] [Abstract][Full Text] [Related]
10. Severity of Nonalcoholic Fatty Liver Disease is Associated With Cardiovascular Outcomes in Patients With Prehypertension or Hypertension: A Community-Based Cohort Study.
Song QR; Liu SL; Ling QH; Gao QN; Yang RX; Chen SH; Wu SL; Chen ML; Cai J
Front Endocrinol (Lausanne); 2022; 13():942647. PubMed ID: 36093080
[TBL] [Abstract][Full Text] [Related]
11. The association of non-alcoholic fatty liver disease and atrial fibrillation: a review.
Käräjämäki AJ; Hukkanen J; Ukkola O
Ann Med; 2018 Aug; 50(5):371-380. PubMed ID: 29929399
[TBL] [Abstract][Full Text] [Related]
12. Prediction of metabolic syndrome by non-alcoholic fatty liver disease in northern urban Han Chinese population: a prospective cohort study.
Zhang T; Zhang Y; Zhang C; Tang F; Li H; Zhang Q; Lin H; Wu S; Liu Y; Xue F
PLoS One; 2014; 9(5):e96651. PubMed ID: 24801211
[TBL] [Abstract][Full Text] [Related]
13. Association between non-alcoholic fatty liver disease and risk of new-onset atrial fibrillation in healthy adults.
Roh JH; Lee JH; Lee H; Yoon YH; Kim M; Kim YG; Park GM; Park JH; Seong IW
Liver Int; 2020 Feb; 40(2):338-346. PubMed ID: 31479572
[TBL] [Abstract][Full Text] [Related]
14. Benign Prostatic Hyperplasia, Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: Is Metaflammation the Link?
Russo GI; Cimino S; Castelli T; Favilla V; Gacci M; Carini M; Condorelli RA; La Vignera S; Calogero AE; Motta F; Puzzo L; Caltabiano R; Morgia G
Prostate; 2016 Dec; 76(16):1528-1535. PubMed ID: 27458062
[TBL] [Abstract][Full Text] [Related]
15. Impact of NAFLD on the Incidence of Cardiovascular Diseases in a Primary Care Population in Germany.
Labenz C; Huber Y; Michel M; Nagel M; Galle PR; Kostev K; Schattenberg JM
Dig Dis Sci; 2020 Jul; 65(7):2112-2119. PubMed ID: 31797186
[TBL] [Abstract][Full Text] [Related]
16. Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up.
Fracanzani AL; Tiraboschi S; Pisano G; Consonni D; Baragetti A; Bertelli C; Norata D; Valenti L; Grigore L; Porzio M; Catapano A; Fargion S
Atherosclerosis; 2016 Mar; 246():208-13. PubMed ID: 26803429
[TBL] [Abstract][Full Text] [Related]
17. Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation.
Pastori D; Nocella C; Farcomeni A; Bartimoccia S; Santulli M; Vasaturo F; Carnevale R; Menichelli D; Violi F; Pignatelli P;
J Am Coll Cardiol; 2017 Sep; 70(12):1455-1462. PubMed ID: 28911508
[TBL] [Abstract][Full Text] [Related]
18. Clinical and Liver Enzymes among the Patients with Metabolic Syndrome with or without Non Alcoholic Fatty Liver Disease attending a Tertiary Care Hospital.
Mondal E; Karim MR; Begum A; Hassan K; Noor SM; Khan MM; Khan KH; Ashrafuzzaman SM
Mymensingh Med J; 2023 Apr; 32(2):338-347. PubMed ID: 37002743
[TBL] [Abstract][Full Text] [Related]
19. Increased Risk for Cardiovascular Events in Patients with Diabetic Kidney Disease and Non-Alcoholic Fatty Liver Disease.
Chinnadurai R; Chrysochou C; Kalra PA
Nephron; 2019; 141(1):24-30. PubMed ID: 30384370
[TBL] [Abstract][Full Text] [Related]
20. Mediterranean Diet: A Tool to Break the Relationship of Atrial Fibrillation with the Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease.
Biccirè FG; Bucci T; Menichelli D; Cammisotto V; Pignatelli P; Carnevale R; Pastori D
Nutrients; 2022 Mar; 14(6):. PubMed ID: 35334916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
